.After antibody-drug conjugate (ADC) expert Seagen was marketed to Pfizer last year for a whopping $...
.On the heels of a phase 3 succeed that failed to wow capitalists, Ironwood Pharmaceuticals is back ...
.Do not stop Monte Rosa Therapeutics right now. The Boston-based biotech is actually having a ball a...
.Welcome to today's Chutes & Ladders, our summary of substantial management hirings, shootings an...
.Celebrating his provider's upsized going public (IPO), Septerna CEO Jeffrey Finer sounded the posit...
.AbbVie has actually returned to the resource of its own antipsychotic goliath Vraylar trying to fin...
.GenSight Biologics is full weeks out of lacking amount of money. Again. The biotech merely has adeq...
.Monopar Therapies is recuperating a drug from the dump of AstraZeneca's uncommon ailment pipe. It h...
.Along with new information out on Arcus Biosciences' experimental HIF-2a inhibitor, one group of ex...
.After creating a gene therapy partnership along with Dyno Rehabs in 2020, Roche is actually back fo...